Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis C news

Show

From To
Almost half of MSM with HIV/HCV co-infection have HCV in their rectal fluid

Almost half of HIV-positive men who have sex with men (MSM) who have co-infection with hepatitis C virus (HCV) have detectable HCV in their rectal fluid,

Published
3 hours ago
By
Michael Carter
Sofosbuvir-based therapy achieves excellent SVR12 rates among people who inject drugs in the Ukraine

People who inject drugs (PWID) can have an excellent response to sofosbuvir-based therapy for hepatitis C virus (HCV) infection, Ukrainian research presented to the recent 2016 AASLD Liver

Published
07 December 2016
By
Michael Carter
First WHO prequalified hepatitis C rapid test opens the door to expanded treatment

WHO has just prequalified its first hepatitis C virus (HCV) rapid diagnostic test, a tool that will aid diagnosis of HCV in low- and middle-income countries and improve access to treatment.

Published
05 December 2016
From
World Health Organization
Hepatitis C drugs Australia's most expensive, cost taxpayers $1 billion in four months

Hepatitis C medications approved in March this year have already topped the list of Australia's most expensive drugs, costing the taxpayer $1 billion. The latest figures have outlined 10 most prescribed and most expensive drugs on the Pharmaceutical Benefits Scheme (PBS) in the past year.

Published
05 December 2016
From
ABC Online
Hepatitis C virus infection is rising among gay and bisexual men in San Diego

The prevalence of hepatitis C virus (HCV) infection among HIV-positive men who have sex with men in San Diego has increased over the past 15 years, especially

Published
05 December 2016
By
Liz Highleyman
New WHO report shows strategic purchasing of medicines can improve access in the European Region

A new WHO report provides insight into how countries in the WHO European Region can improve access and reduce medicine prices through strategic and well-planned procurement processes. The report examines the effect of different public procurement practices on supply security and prices for pharmaceuticals. It also addresses collaboration within and across countries to improve availability of affordable medicines for patients in the Region.

Published
02 December 2016
From
World Health Organization
Hepatitis C Sheds Enough in the Rectum to Transmit Through Anal Sex

Researchers have come up with the first direct evidence that enough hepatitis C virus (HCV) sheds into the rectums of HIV-positive men who have sex with men (MSM) to transmit directly to another man’s penis during anal sex, even when no blood is present.

Published
30 November 2016
From
Poz
DAA treatment restricted for Canadian hepatitis C patients

Patients infected by hepatitis C virus (HCV) in Canada have limited access to direct-acting antiviral (DAA) agents, according to a new study. For example, 85% to 92% of the provinces and territories in Canada restrict access to these medications to persons with moderate fibrosis.

Published
29 November 2016
From
Medical Economics
Sofosbuvir/ledipasvir is effective for people with HIV/HCV co-infection in real-world clinical practice

The sofosbuvir/ledipasvir (Harvoni) co-formulation used in real-world clinical practice produced good sustained virological response rates similar to those seen in clinical trials for HIV-positive people with hepatitis

Published
28 November 2016
By
Liz Highleyman
Grazoprevir triple regimen demonstrates high cure rates, even for hard-to-treat people

A new three-drug co-formulation containing Merck's grazoprevir plus the investigational agents MK-3682 and ruzasvir was highly effective for people with hepatitis C virus (HCV) genotypes 1, 2

Published
25 November 2016
By
Liz Highleyman
← First12345...166Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.